Correlation Between Alto Neuroscience, and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and Enliven Therapeutics, you can compare the effects of market volatilities on Alto Neuroscience, and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Enliven Therapeutics.
Diversification Opportunities for Alto Neuroscience, and Enliven Therapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alto and Enliven is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and Enliven Therapeutics
Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the Enliven Therapeutics. In addition to that, Alto Neuroscience, is 2.46 times more volatile than Enliven Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 2,093 in Enliven Therapeutics on September 2, 2024 and sell it today you would earn a total of 345.00 from holding Enliven Therapeutics or generate 16.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alto Neuroscience, vs. Enliven Therapeutics
Performance |
| Timeline |
| Alto Neuroscience, |
| Enliven Therapeutics |
Alto Neuroscience, and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alto Neuroscience, and Enliven Therapeutics
The main advantage of trading using opposite Alto Neuroscience, and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Alto Neuroscience, vs. Crinetics Pharmaceuticals | Alto Neuroscience, vs. Enanta Pharmaceuticals | Alto Neuroscience, vs. Amicus Therapeutics | Alto Neuroscience, vs. Connect Biopharma Holdings |
| Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |